Korro to participate in upcoming september investor and scientific conferences

Cambridge, mass., aug. 27, 2024 (globe newswire) -- korro bio, inc. (korro) (nasdaq: krro) a biopharmaceutical company focused on developing a new class of genetic medicines based on editing rna for both rare and highly prevalent diseases, today announced that members of management will participate in the following investor and scientific conferences:
KRRO Ratings Summary
KRRO Quant Ranking